A detailed history of O'Shaughnessy Asset Management, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 22,940 shares of ADMA stock, worth $356,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,940
Previous 22,390 2.46%
Holding current value
$356,028
Previous $447,000 12.08%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$15.62 - $22.62 $8,591 - $12,441
550 Added 2.46%
22,940 $393,000
Q3 2024

Nov 12, 2024

BUY
$11.21 - $20.03 $103,188 - $184,376
9,205 Added 69.81%
22,390 $447,000
Q2 2024

Aug 14, 2024

BUY
$5.98 - $11.18 $78,846 - $147,408
13,185 New
13,185 $147,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.05B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.